These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16221905)

  • 1. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB; Pilgram TK; Brown DB
    J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
    Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiofrequency ablation after transarterial embolization as therapy for patients with unresectable hepatocellular carcinoma.
    Liao GS; Yu CY; Shih ML; Chan DC; Liu YC; Yu JC; Chen TW; Hsieh CB
    Eur J Surg Oncol; 2008 Jan; 34(1):61-6. PubMed ID: 17434711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined treatment, TACE and RF ablation, in HCC: preliminary results.
    Gasparini D; Sponza M; Marzio A; Zanardi R; Bazzocchi M; Cemal Y
    Radiol Med; 2002; 104(5-6):412-20. PubMed ID: 12589262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
    Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
    Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
    Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
    Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
    Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
    Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation.
    Lao OB; Weissman J; Perkins JD
    Clin Transplant; 2009; 23(6):874-81. PubMed ID: 19453644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation.
    Komorizono Y; Oketani M; Sako K; Yamasaki N; Shibatou T; Maeda M; Kohara K; Shigenobu S; Ishibashi K; Arima T
    Cancer; 2003 Mar; 97(5):1253-62. PubMed ID: 12599233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience.
    Chen TM; Huang PT; Lin LF; Tung JN
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e445-50. PubMed ID: 17683478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation for hepatocellular carcinoma and metastatic liver tumors: a comparative study.
    Chow DH; Sinn LH; Ng KK; Lam CM; Yuen J; Fan ST; Poon RT
    J Surg Oncol; 2006 Dec; 94(7):565-71. PubMed ID: 17048238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].
    Lü MD; Kuang M; Liang LJ; Xie XY; Peng BG; Liu GJ; Li DM; Lai JM; Li SQ
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(12):801-5. PubMed ID: 16681964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.